Validity of anthropometric indices in predicting high blood pressure risk factors in Iranian children and adolescents: CASPIAN-V study.


Journal

Journal of clinical hypertension (Greenwich, Conn.)
ISSN: 1751-7176
Titre abrégé: J Clin Hypertens (Greenwich)
Pays: United States
ID NLM: 100888554

Informations de publication

Date de publication:
06 2020
Historique:
received: 24 03 2020
revised: 18 04 2020
accepted: 27 04 2020
pubmed: 9 6 2020
medline: 8 6 2021
entrez: 8 6 2020
Statut: ppublish

Résumé

Anthropometric indices have been used as indicators for predicting hypertension (HTN) in children and adolescents but it is not clear which anthropometric measures are a better index for identifying elevated blood pressure (EBP) risk factors in pediatric population. Body mass index (BMI), waist circumference (WC), weight-height ratio (WHR), a body shape index (ABSI) and blood pressure were measured in 14 008 children and adolescents aged 7-18 years in a national school-aged survey CASPIN V. Hypertension (HTN) was defined according to the 2017 American Academy of Pediatrics guidelines, using the 95th percentile. The predictive power of anthropometric indices for HTN risk factors was examined using receiver operating characteristic (ROC) analyses. Multivariate logistic regression analysis was used to compare areas under ROC curves (AUCs) among the four anthropometric indices. BMI, WC, WHR, and ABSI were significantly higher in adolescents than in children. EBP was more prevalent in boys (7.2%) than girls (5.5%), whereas the prevalence of HTN was higher in girls (11.3%) than boys 10.4%. Prevalence odds ratio was around 2 for BMI, WC, and WHR with AUCs scores of nearly 0.6 to predict EBP in both children and adolescents of both sexes. Thus, the ability of BMI z-score, WC, WHR or ASBI to identify Iranian children and adolescents at higher risk of EBP was week. WC, WHR or ASBI in combination with BMI did not improve predictive power to identify subjects at higher risk of EBP.

Identifiants

pubmed: 32506679
doi: 10.1111/jch.13895
pmc: PMC8029738
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1009-1017

Informations de copyright

© 2020 Wiley Periodicals LLC.

Références

J Pediatr. 2014 Dec;165(6):1178-1183.e2
pubmed: 25112691
PLoS One. 2014 Feb 20;9(2):e88793
pubmed: 24586394
J Clin Hypertens (Greenwich). 2020 Jun;22(6):1009-1017
pubmed: 32506679
J Hum Hypertens. 2020 Apr;34(4):319-325
pubmed: 31253844
PLoS One. 2018 Jan 3;13(1):e0190426
pubmed: 29298340
Int J Prev Med. 2017 Jan 23;8:4
pubmed: 28217266
Circulation. 2007 Feb 6;115(5):654-7
pubmed: 17283280
Ann Hum Biol. 2017 Sep;44(6):489-494
pubmed: 28482705
Medicine (Baltimore). 2016 Nov;95(44):e5301
pubmed: 27858905
Hypertension. 2002 Jul;40(1):7-12
pubmed: 12105130
J Obes. 2016;2016:8094275
pubmed: 27830087
Int J Epidemiol. 2011 Feb;40(1):33-44
pubmed: 21044977
Pediatrics. 2006 Nov;118(5):e1390-8
pubmed: 17079540
Diabetes Care. 2011 Jan;34(1):e7
pubmed: 21193616
Int J Pediatr Obes. 2011 Aug;6(3-4):229-35
pubmed: 21668385
Acta Paediatr Suppl. 2006 Apr;450:76-85
pubmed: 16817681
Arq Bras Cardiol. 2011 Feb;96(2):126-33
pubmed: 21085760
Pediatr Diabetes. 2019 Aug;20(5):530-537
pubmed: 30968521
J Atheroscler Thromb. 2016;23(3):320-9
pubmed: 26423717
Eur J Nutr. 2013 Feb;52(1):57-65
pubmed: 22160169
Obesity (Silver Spring). 2012 Oct;20(10):2118-23
pubmed: 22517513
Pediatrics. 2011 Dec;128 Suppl 5:S213-56
pubmed: 22084329
Pediatrics. 2017 Sep;140(3):
pubmed: 28827377
J Hum Hypertens. 2015 Dec;29(12):732-6
pubmed: 25787781
Hypertension. 2019 Jun;73(6):1224-1230
pubmed: 31067199
PLoS One. 2011;6(5):e19835
pubmed: 21625549
PLoS One. 2020 Jan 21;15(1):e0227954
pubmed: 31961891
Blood Press. 2013 Feb;22(1):17-20
pubmed: 22817261
Obes Rev. 2018 May;19(5):737-759
pubmed: 29349876
Pediatrics. 2016 Mar;137(3):e20151662
pubmed: 26908707
BMJ Open. 2017 Sep 18;7(9):e016062
pubmed: 28928179
Bull World Health Organ. 2007 Sep;85(9):660-7
pubmed: 18026621
J Obes. 2013;2013:790654
pubmed: 23691288
Biom J. 2005 Aug;47(4):458-72
pubmed: 16161804
Pediatr Int. 2010 Jun;52(3):402-9
pubmed: 19807877
PLoS One. 2014 Sep 17;9(9):e107212
pubmed: 25229394
BMJ Open. 2020 Jan 12;10(1):e032874
pubmed: 31932391
Ann Hum Biol. 2015 Jan;42(1):70-5
pubmed: 24734976
Am J Hypertens. 2013 Jan;26(1):58-67
pubmed: 23382328
Am J Clin Nutr. 2012 Mar;95(3):594-602
pubmed: 22301924
PLoS One. 2012;7(7):e39504
pubmed: 22815707
Pediatr Obes. 2015 Oct;10(5):329-37
pubmed: 25515620
JAMA. 2016 Jun 7;315(21):2292-9
pubmed: 27272581
Obes Rev. 2016 Dec;17(12):1258-1275
pubmed: 27452904
Tohoku J Exp Med. 1999 May;188(1):55-60
pubmed: 10494900
Sci Rep. 2016 Dec 21;6:39480
pubmed: 28000763
BMC Public Health. 2015 Jan 17;15:7
pubmed: 25595192
PLoS One. 2016 Feb 22;11(2):e0149351
pubmed: 26901828

Auteurs

Mayram Yazdi (M)

Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran.

Farahnak Assadi (F)

Department of Pediatrics, Rush University Medical College, Chicago, IL, USA.

Mostafa Qorbani (M)

Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran.
Chronic Research Center, Epidemiology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Seyede Shahbanoo Daniali (SS)

Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran.

Ramin Heshmat (R)

Chronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Mohammad Esmaeil Motlagh (M)

Department of Pediatrics, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Roya Kelishadi (R)

Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH